Qingcheng New Pharmaceutical-B (02396.HK) recommends adopting the share incentive plan.

Zhihui Finance APP News, Qingcheng New Drug-B (02396.HK) announced that on August 14, 2026, the Board of Directors approved the proposed adoption of a share incentive plan, subject to shareholder approval. The share incentive plan constitutes a share scheme under Chapter 17 of the Listing Rules and will therefore comply with the provisions of Chapter 17 of the Listing Rules. On August 14, 2026, the Board of Directors resolved to grant initial conditional awards under the share incentive plan to one employee and one advisor.